
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FOXM1-Activated LINC01094 Promotes Clear Cell Renal Cell Carcinoma Development via MicroRNA 224-5p/CHSY1
Yufeng Jiang, Haimin Zhang, Wei Li, et al.
Molecular and Cellular Biology (2019) Vol. 40, Iss. 3
Open Access | Times Cited: 66
Yufeng Jiang, Haimin Zhang, Wei Li, et al.
Molecular and Cellular Biology (2019) Vol. 40, Iss. 3
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma
Jiayi Lai, Shiqi Miao, Longke Ran
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Jiayi Lai, Shiqi Miao, Longke Ran
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment
Qi Zhang, Hao Ren, Luqi Ge, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Qi Zhang, Hao Ren, Luqi Ge, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
LINC01094/miR-577 axis regulates the progression of ovarian cancer
Jing Xu, Ping Zhang, Huajun Sun, et al.
Journal of Ovarian Research (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Jing Xu, Ping Zhang, Huajun Sun, et al.
Journal of Ovarian Research (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 41
LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration
Yuanchun Ye, Ouyang Ge, Chuanbing Zang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 26
Yuanchun Ye, Ouyang Ge, Chuanbing Zang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 26
LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway
Chen Luo, Lin Kang, Cegui Hu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 523-535
Open Access | Times Cited: 31
Chen Luo, Lin Kang, Cegui Hu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 523-535
Open Access | Times Cited: 31
Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis
Yingli Sui, Kun Lü, Lin Fu
PeerJ (2021) Vol. 9, pp. e11272-e11272
Open Access | Times Cited: 28
Yingli Sui, Kun Lü, Lin Fu
PeerJ (2021) Vol. 9, pp. e11272-e11272
Open Access | Times Cited: 28
Inflammation-Related Long Non-Coding RNA Signature Predicts the Prognosis of Gastric Carcinoma
Shuqiao Zhang, Xinyu Li, Chunzhi Tang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 28
Shuqiao Zhang, Xinyu Li, Chunzhi Tang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 28
An angiogenesis-related three-long non-coding ribonucleic acid signature predicts the immune landscape and prognosis in hepatocellular carcinoma
Wenjuan Wang, Yingquan Ye, Xuede Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13989-e13989
Open Access | Times Cited: 13
Wenjuan Wang, Yingquan Ye, Xuede Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13989-e13989
Open Access | Times Cited: 13
LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma
Э. А. Брага, М. В. Фридман, Е. А. Филиппова, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11193-11193
Open Access | Times Cited: 27
Э. А. Брага, М. В. Фридман, Е. А. Филиппова, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11193-11193
Open Access | Times Cited: 27
miR-224-5p Contained in Urinary Extracellular Vesicles Regulates PD-L1 Expression by Inhibiting Cyclin D1 in Renal Cell Carcinoma Cells
Zhiyuan Qin, Haihong Hu, Wen Sun, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 618-618
Open Access | Times Cited: 26
Zhiyuan Qin, Haihong Hu, Wen Sun, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 618-618
Open Access | Times Cited: 26
Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis
Xia Wu, Cui Kong, Yi‐Lei Wu
Bioengineered (2021) Vol. 12, Iss. 1, pp. 9046-9057
Open Access | Times Cited: 25
Xia Wu, Cui Kong, Yi‐Lei Wu
Bioengineered (2021) Vol. 12, Iss. 1, pp. 9046-9057
Open Access | Times Cited: 25
Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma
Huijie Zhang, Lei Yu, Jing Chen, et al.
Journal of Cancer (2022) Vol. 13, Iss. 2, pp. 691-705
Open Access | Times Cited: 19
Huijie Zhang, Lei Yu, Jing Chen, et al.
Journal of Cancer (2022) Vol. 13, Iss. 2, pp. 691-705
Open Access | Times Cited: 19
Jiao Tian, Yiming He, Zihui Zhang, et al.
Thoracic Cancer (2025) Vol. 16, Iss. 2
Open Access
Long Non-coding RNA LINC01094 Promotes the Development of Clear Cell Renal Cell Carcinoma by Upregulating SLC2A3 via MicroRNA-184
Haifei Xu, Xiaolin Wang, Jiacheng Wu, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 27
Haifei Xu, Xiaolin Wang, Jiacheng Wu, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 27
<p>Linc01094 Accelerates the Growth and Metastatic-Related Traits of Glioblastoma by Sponging miR-126-5p</p>
Xin Xing Li, Qi Yu
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 9917-9928
Open Access | Times Cited: 26
Xin Xing Li, Qi Yu
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 9917-9928
Open Access | Times Cited: 26
<p>LINC01094 Down-Regulates miR-330-3p and Enhances the Expression of MSI1 to Promote the Progression of Glioma</p>
Bin Zhu, Wei Liu, Hongliang Liu, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 6511-6521
Open Access | Times Cited: 25
Bin Zhu, Wei Liu, Hongliang Liu, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 6511-6521
Open Access | Times Cited: 25
Ferroptosis‑related long non‑coding RNAs and the roles of LASTR in stomach adenocarcinoma
Gongjun Wang, Libin Sun, Shasha Wang, et al.
Molecular Medicine Reports (2022) Vol. 25, Iss. 4
Open Access | Times Cited: 15
Gongjun Wang, Libin Sun, Shasha Wang, et al.
Molecular Medicine Reports (2022) Vol. 25, Iss. 4
Open Access | Times Cited: 15
FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway
Zhengtong Lv, Miao Wang, Huimin Hou, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3293-3306
Open Access | Times Cited: 9
Zhengtong Lv, Miao Wang, Huimin Hou, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3293-3306
Open Access | Times Cited: 9
Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients
Mingjie Yuan, Yanfei Jia, Yuanxin Xing, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Mingjie Yuan, Yanfei Jia, Yuanxin Xing, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
Rongkang Li, Wenkang Chen, Chong Lu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 8
Rongkang Li, Wenkang Chen, Chong Lu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 8
A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma
Guocheng Huang, Xinji Li, Zebo Chen, et al.
Pathology & Oncology Research (2020) Vol. 26, Iss. 4, pp. 2425-2434
Closed Access | Times Cited: 20
Guocheng Huang, Xinji Li, Zebo Chen, et al.
Pathology & Oncology Research (2020) Vol. 26, Iss. 4, pp. 2425-2434
Closed Access | Times Cited: 20
LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway
Jiandong Li, Xiaohu Xu, Dandan Zhang, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 2293-2300
Open Access | Times Cited: 17
Jiandong Li, Xiaohu Xu, Dandan Zhang, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 2293-2300
Open Access | Times Cited: 17
Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
Xin Hu, Liuxing Wu, Ben Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Xin Hu, Liuxing Wu, Ben Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
LINC01094 promotes the invasion of ovarian cancer cells and regulates the Wnt/β‑catenin signaling pathway by targeting miR‑532‑3p
Haiyan Chen, Yanlin Liu, Ping Liu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 15
Haiyan Chen, Yanlin Liu, Ping Liu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 15
PLAUR facilitates the progression of clear cell renal cell carcinoma by activating the PI3K/AKT/mTOR signaling pathway
Tianzi Qin, Min-Yu Huang, Wenjuan Wei, et al.
PeerJ (2024) Vol. 12, pp. e17555-e17555
Open Access | Times Cited: 2
Tianzi Qin, Min-Yu Huang, Wenjuan Wei, et al.
PeerJ (2024) Vol. 12, pp. e17555-e17555
Open Access | Times Cited: 2